Innovation Week begins Monday

Image with file name: Demo0918.jpg
Brian Johns, Ph.D., GlaxoSmithKline's director of HIV medicinal chemistry, will deliver a one-hour presentation about Tivicay, a reportedly more effective and less expensive HIV treatment recently approved last month by the FDA.

The seminar, called "Making a Difference: The Discovery and Development of Tivicay," will be held at 10 a.m. Tuesday in the Durham Research Center auditorium as part of Innovation Week.

Sponsored by UNeMed Corporation, Innovation Week is a series of events celebrating the innovation and research at UNMC. For a complete schedule of Innovation Week events, beginning Monday and running through Thursday, click here.

At 9 a.m. Monday in the DRC atrium, UNeMed will host an open house. Visitors can register for a chance at a free iPad and pick up free UNeMed T-shirts and other goodies.

At 2:30 p.m. Monday, UNeMed will host the inaugural UNMC Startup Company Demonstration Day in the DRC auditorium. Demonstration Day, a free event, will feature at least eight new companies formed on the basis of technology developed at UNMC. Each company will deliver a short, 10-minute presentation, followed by a brief question and answer forum. UNeMed will then host a reception in the atrium with complimentary snacks and refreshments.

Space is limited, so reserve a seat for UNMC Startup Company Demonstration Day here.

Innovation Week culminates on Thursday with the UNMC Research Innovation Awards ceremony and reception beginning at 4 p.m. The awards ceremony will recognize the new inventions, patents and licensed technologies at UNMC over the previous year, and UNeMed will present two special awards honoring an "Innovator of the Year" and the "Most Promising New Invention." The free iPad winner also will be announced during the ceremony, but the entrant must be present to win.

The event is free, but space is limited, so reserve a seat for the Innovation Awards here.


Fill out the following and your comment will post once it has been approved.

Thank you, your comment will appear below once it has been approved.